BioMarin Pharmaceutical | 资产

Assets 更改 日
Acadia Pharmaceuticals USD 855.1M 106.15M 2024-03
Agios Pharmaceuticals USD 849.71M 87.41M 2024-03
Alnylam Pharmaceuticals USD 3.82B 5.49M 2024-03
Amgen USD 92.98B 4.17B 2024-03
Bayer EUR 119.88B 3.62B 2024-03
Biogen USD 26.57B 277.2M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Gilead Sciences USD 56.29B 5.83B 2024-03
Incyte USD 7.14B 353.5M 2024-03
Insmed USD 1.16B 170.74M 2024-03
Ionis Pharmaceuticals USD 2.76B 226.14M 2024-03
Moderna USD 16.73B 1.7B 2024-03
Neurocrine Biosciences USD 3.47B 624.2M 2024-03
PTC Therapeutics USD 1.79B 106.07M 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Roche Holding CHF 90.47B 6.1B 2023-12
Sarepta Therapeutics USD 3.22B 114.68M 2024-03
Ultragenyx Pharmaceutical USD 1.31B 183.93M 2024-03
United Therapeutics USD 6.5B 671.8M 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03



BioMarin Pharmaceutical 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.